Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson's disease
2019
Abstract Introduction
Autonomic neuropathyis common in
Parkinson's disease(PD). We evaluated whether SUDOSCAN, a novel electrophysiological device that provides a simple and quantitative assessment of
sudomotorfunction, was able to detect PD-related
autonomic neuropathy. We also used the device to examine potential risk factors for PD-related
autonomic neuropathy. Methods Forty-three hospitalized patients in the later stages of PD underwent assessments including a clinical history, the
Unified Parkinson's Disease Rating Scale(UPDRS), the Scale for Outcomes in
Parkinson's diseasefor
AutonomicSymptoms (
SCOPA-AUT), and measurement of homocysteine (HCY) and vitamin B12 levels.
Sudomotorfunction was assessed by measuring electrochemical
skin conductance(ESC) using SUDOSCAN. Forty-two healthy participants served as controls. Results ESC of the limbs, and especially the hands, was significantly lower in PD patients than in controls and was significantly correlated with
SCOPA-AUT results. ESC was strongly negatively correlated with PD duration. The results also indicated that
levodopaexposure and a higher HCY level may be risk factors for PD-related
autonomic neuropathy. Conclusions SUDOSCAN was able to effectively identify
autonomic neuropathyin PD patients. ESC was decreased in PD patients and was correlated with PD-related
autonomicsymptoms. These findings suggest that SUDOSCAN could be a promising new method for assessing PD-related
autonomic neuropathy.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
30
References
8
Citations
NaN
KQI